Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

Source:http://linkedlifedata.com/resource/pubmed/id/10505460

Download in:

View as

General Info

PMID
10505460